SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-025683
Filing Date
2014-04-29
Accepted
2014-04-29 16:00:41
Documents
9
Period of Report
2014-06-12
Effectiveness Date
2014-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A v376070_def14a.htm DEF 14A 404718
2 GRAPHIC v376070_proxycd1.jpg GRAPHIC 320215
3 GRAPHIC v376070_proxycd2.jpg GRAPHIC 179290
4 GRAPHIC v376070_proxycd3.jpg GRAPHIC 384480
5 GRAPHIC line.gif GRAPHIC 43
6 GRAPHIC logo_celator.jpg GRAPHIC 15680
7 GRAPHIC sig_joseph-mollica.jpg GRAPHIC 7160
8 GRAPHIC sig_scott-jackson.jpg GRAPHIC 6104
9 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-14-025683.txt   1664870
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36179 | Film No.: 14793798
SIC: 2834 Pharmaceutical Preparations